期刊文献+

颗粒裂解肽G13结构域在大肠杆菌中的高效融合表达 被引量:5

Efficient fusion expression of G13 domain derived from granulysin in Escherichia coli
原文传递
导出
摘要 为高效表达颗粒裂解肽G13结构域并避免G13对宿主菌的毒性,将人工合成的编码G13的基因片段,PCR扩增后克隆于原核表达载体pThioHisA中,构建了重组表达载体pThioHisA-G13,将其转化于大肠杆菌BL21(DE3)中,经IPTG诱导表达融合蛋白Trx-G13,表达产物以包涵体的形式存在,其表达量约占细菌总蛋白的58%。包涵体蛋白经8 mol/L尿素溶解后,再经CNBr切割,阳离子交换层析,得到纯化的重组G13结构域。琼脂糖扩散法检测表明重组G13结构域多肽具有抗菌活性。 The G13 domain derived from granulysin shows high antimicrobial activities against Gram-positive and Gram-negative bacteria but does not lyse Jurkat cells or liposomes. To explore a new approach for high expression of the G13 domain, we fused the sequence encoding G13 to thioredoxin (Trx) gene to construct the recombinant expression vector (pThioHisA-G13). A cyanogen bromide (CNBr) cleavage site was introduced between the Trx and G13 to facilitate final release of the recombinant G13. The recombinant expression vector, pThioHisA-G13, was transformed into E. coli BL21 (DE3). Upon induction by IPTG, Trx-G13 fusion protein was expressed and took the form of inclusion bodies counting 58% (W/W) of total cellular proteins. The inclusion body was solved by urea (8 mol/L) and then cleaved by CNBr. We purified the recombinant peptide G13 by one-step cation exchange chromatography. Results of agarose diffuse assay analysis indicated that the recombinant G13 exhibited antibacterial activity. The procedure described in this study will provide a reliable and simple method for highly efficient production of some cationic antimicrobial peptides.
出处 《生物工程学报》 CAS CSCD 北大核心 2009年第2期235-241,共7页 Chinese Journal of Biotechnology
基金 安徽省高校省级自然科学研究重点项目(No.KJ2007A091) 安徽大学211工程学术创新团队项目(No.02203109)资助~~
关键词 颗粒裂解肽 G13结构域 融合表达 阳离子抗菌肽 Granulysin, G13 domain, fusion expression, cationic antimicrobial peptide
  • 相关文献

参考文献18

  • 1Guerreiro CI, Fontes CM, Gama M, et al. Escherichia coli expression and purification of four antimicrobial peptides fused to a family 3 carbohydrate-binding module (CBM) from Clostridium thermocellum. Protein Expr Purif, 2008, 59(1): 161-168.
  • 2Bonomo RA. Multiple antibiotic-resistant bacteriain in long-term-care facilities: an emerging problem in the practice of infectious diseases. Clin Infect Dis, 2000, 31(6): 1414-1422.
  • 3Clayberger C, Krensky AM. Granulysin. Curr Opin Immol, 2003, 15(5): 560-565.
  • 4Wang Z, Choice E, Kaspar A, et al. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J lmmol Lunol, 2000, 165(3): 1486-1490.
  • 5Xu XX, Jin FL, Yu XQ, et al. High-level expression of the recombinant hybrid peptide cecropinA (1-8)-magainin2 (1-12) with an ubiquitin fusion partner in Escheriehia eoli. Protein Expr Purif, 2007, 55(1): 175-182.
  • 6Rodriguez JC, Wong L, Jennings PA. The solvent in CNBr cleavage reactions determines the fragmentation efficiency of ketosteroid isomerase fusion proteins used in the production of recombinant peptides. Protein Expr Purif, 2003, 28(2): 224-231.
  • 7李保存,陈玉清,刘平,张双全.中国家蚕抗菌肽ABP-CM4在E.coli中的融合表达及活性分析[J].分子细胞生物学报,2007,40(2):98-102. 被引量:5
  • 8Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science, 1998, 282(5386): 121-125.
  • 9陆海荣,李国栋,吴宏宇,黄晋江,汪世龙,黄青山.抗菌肽GK1在大肠杆菌中的融合表达[J].生物工程学报,2008,24(1):21-26. 被引量:16
  • 10查向东,徐康森,刘兢.阳离子抗菌肽研究进展[J].中国药理学通报,2003,19(7):735-740. 被引量:13

二级参考文献111

共引文献39

同被引文献46

  • 1吴加金 李伍举 等.影响外源基因在原核中表达水平因素分析[J].生物工程学报,1997,12:92-96.
  • 2Linde M A,Grundstrom S,Nordling E,et al.Conserved structure and function in the granulysin and NK-Lysin peptide family[J].American Society for Microbiology,2005,73(10):6332-6339.
  • 3Wang Z,Choice E,Kaspar A,et al.Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin[J].J Immol Lunol,2000,165(3):1486-1490.
  • 4Andreu D,Carreno C,Lindey C,et al.Identification of an anti-mycobacterial domain in NK-lysin and granulysin[J].Biochemical Society,1999,344:845-849.
  • 5王作利,查向东,周鹏,等.融合头的改变对抑制重组抗菌肽毒性的影响[C].医学分子生物学和免疫学学术交流研讨会论文集,深圳,2009.
  • 6周鹏,查向东,王作利.共表达阴离子配体生产重组阳离子抗菌肽的研究[C].抗菌肽开发与应用技术研讨会论文集,深圳,2009:8-12.
  • 7查向东,周鹏.共表达阴离子配体重组生产阳离子抗菌肽的方法[P].中国专利:20091018520.4.
  • 8Gold L.Post-transcriptional regulatory mechanisms in Escherichia coli[J].Annu Rev Biophys Chem,1998,57:199.
  • 9Schagger H.Tricine-SDS-PAGE.Nature Protocols,2006:16-22.
  • 10Park Y, Hahm K S. Antimicrobial peptides (AMPs): Peptide structure and mode of action[J]. Biochem Mol Biol, 2005, 38(5): 507-16.

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部